Seo Hyeonseok, Kim Yaechan, Kim Dongryeong, Kang Hanul, Park Chansu, Park Sejin, Kang Junha, Oh Janghyeog, Kang Hyunsung, Han Mi Ah
Department of Premedicine, Chosun University College of Medicine, Gwangju, Korea.
Department of Preventive Medicine, Chosun University College of Medicine, Gwangju, Korea.
Healthc Inform Res. 2024 Jul;30(3):277-285. doi: 10.4258/hir.2024.30.3.277. Epub 2024 Jul 31.
This study compared the scientific publication speeds of Korean medical journals before and during the coronavirus disease 2019 (COVID-19) era.
We analyzed 2,064 papers from 43 international Korean medical journals, selecting 12 papers annually from 2019 to 2022. We assessed publication speed indicators, including the time from submission to revision and from submission to publication. Additionally, we examined variations in publication speed based on journal and paper characteristics, including whether the studies were related to COVID-19.
Among the 43 journals analyzed, 39.5% disclosed the peer review duration from submission to the first decision, and 11.6% reported their acceptance rates. The average time from submission to acceptance was 127.0 days in 2019, 126.1 days in 2020, 124.6 days in 2021, and 126.4 days in 2022. For COVID-19-related studies, the average time from submission to revision was 61.4 days, compared to 105.1 days for non-COVID-19 studies; from submission to acceptance, it was 87.4 days for COVID-19-related studies and 127.1 days for non-COVID-19 studies. All indicators for COVID-19-related studies showed shorter durations than those for non-COVID-19 studies, and the proportion of studies accepted within 30 or 60 days was significantly higher for COVID-19-related studies.
This study investigated the publication speed of Korean international medical journals before and during the COVID-19 pandemic. The pandemic influenced journals' review and publication processes, potentially impacting the quality of academic papers. These findings provide insights into publication speeds during the COVID-19 era, suggesting that journals should focus on maintaining the integrity of their publication and review processes.
本研究比较了2019冠状病毒病（COVID-19）疫情之前和期间韩国医学期刊的论文发表速度。
我们分析了43种韩国国际医学期刊的2064篇论文，从2019年至2022年每年选取12篇论文。我们评估了发表速度指标，包括从投稿到返修以及从投稿到发表的时间。此外，我们还根据期刊和论文特征，包括研究是否与COVID-19相关，研究了发表速度的差异。
在分析的43种期刊中，39.5%披露了从投稿到首次决定的同行评审时长，11.6%报告了其录用率。从投稿到录用的平均时间在2019年为127.0天，2020年为126.1天，2021年为124.6天，2022年为126.4天。对于与COVID-19相关的研究，从投稿到返修的平均时间为61.4天，而非COVID-19研究为105.1天；从投稿到录用，与COVID-19相关的研究为87.4天，非COVID-19研究为127.1天。与COVID-19相关研究的所有指标显示的时长均短于非COVID-19研究，且与COVID-19相关研究在30天或60天内被录用的比例显著更高。
本研究调查了COVID-19大流行之前和期间韩国国际医学期刊的发表速度。该大流行影响了期刊的评审和发表过程，可能会影响学术论文的质量。这些发现为COVID-19时代的发表速度提供了见解，表明期刊应专注于保持其发表和评审过程的完整性。
